top of page
>
>
Platform technology technical evaluation and deal trends
Client Problems
- A large biopharmaceutical company wanted to evaluate 3 novel platform technologies in development based on technical merits and feasibility
- The client wanted to determine the degree to which they would integrate and harmonize with their current portfolio and disease areas of focus
- Lastly, the client wanted to understand the competitive landscape and recent deal trends for prioritized platform(s)
What We Did
- Performed a technical deep dive into each of the therapeutic platform technologies and its applications
- Determined the technical hurdles , opportunities and challenges of each platform technology
- Identified key milestones, current clinical trials and gathered competitive intelligence on the major players in the space
- Identified top deals, partnerships, and investment trends for prioritized technologies
Our Results And Insight
- Deep dive into each platform technology and determine its current and future applications
- Comparison of two platform technologies for solid tumor indications
- Identified key clinical trials for each platform technology
- Deals and partnerships in for each platform technology
See other case studies
Commercial Strategy case studies >
Other Therapeutic Areas case studies >
Gene Therapy & Orphan Disease case studies >
Service Areas Details
Commercial Strategy (Technical Assessment)
Therapeutic Areas Details
Other Therapeutic Areas (CAR-T, CRISPR), Gene Therapy
Featured Consultants
bottom of page